261 related articles for article (PubMed ID: 21565552)
1. FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
Stechschulte LA; Sanchez ER
Curr Opin Pharmacol; 2011 Aug; 11(4):332-7. PubMed ID: 21565552
[TBL] [Abstract][Full Text] [Related]
2. Steroid up-regulation of FKBP51 and its role in hormone signaling.
Jääskeläinen T; Makkonen H; Palvimo JJ
Curr Opin Pharmacol; 2011 Aug; 11(4):326-31. PubMed ID: 21531172
[TBL] [Abstract][Full Text] [Related]
3. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.
Periyasamy S; Hinds T; Shemshedini L; Shou W; Sanchez ER
Oncogene; 2010 Mar; 29(11):1691-701. PubMed ID: 20023700
[TBL] [Abstract][Full Text] [Related]
4. Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology.
Yong W; Yang Z; Periyasamy S; Chen H; Yucel S; Li W; Lin LY; Wolf IM; Cohn MJ; Baskin LS; Sa Nchez ER; Shou W
J Biol Chem; 2007 Feb; 282(7):5026-5036. PubMed ID: 17142810
[TBL] [Abstract][Full Text] [Related]
5. The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.
Cluning C; Ward BK; Rea SL; Arulpragasam A; Fuller PJ; Ratajczak T
Mol Endocrinol; 2013 Jul; 27(7):1020-35. PubMed ID: 23686112
[TBL] [Abstract][Full Text] [Related]
6. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.
Wochnik GM; Rüegg J; Abel GA; Schmidt U; Holsboer F; Rein T
J Biol Chem; 2005 Feb; 280(6):4609-16. PubMed ID: 15591061
[TBL] [Abstract][Full Text] [Related]
7. The FKBP51-Glucocorticoid Receptor Balance in Stress-Related Mental Disorders.
Fries GR; Gassen NC; Schmidt U; Rein T
Curr Mol Pharmacol; 2015; 9(2):126-40. PubMed ID: 25986564
[TBL] [Abstract][Full Text] [Related]
8. FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness.
Zhang X; Clark AF; Yorio T
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1037-47. PubMed ID: 18326728
[TBL] [Abstract][Full Text] [Related]
9. Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins.
LeMaster DM; Mustafi SM; Brecher M; Zhang J; Héroux A; Li H; Hernández G
J Biol Chem; 2015 Jun; 290(25):15746-15757. PubMed ID: 25953903
[TBL] [Abstract][Full Text] [Related]
10. The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.
Fries GR; Gassen NC; Rein T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29206196
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51.
Westberry JM; Sadosky PW; Hubler TR; Gross KL; Scammell JG
J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):34-41. PubMed ID: 16723223
[TBL] [Abstract][Full Text] [Related]
12. FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.
Ni L; Yang CS; Gioeli D; Frierson H; Toft DO; Paschal BM
Mol Cell Biol; 2010 Mar; 30(5):1243-53. PubMed ID: 20048054
[TBL] [Abstract][Full Text] [Related]
13. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
[TBL] [Abstract][Full Text] [Related]
14. FKBP51 and the molecular chaperoning of metabolism.
Smedlund KB; Sanchez ER; Hinds TD
Trends Endocrinol Metab; 2021 Nov; 32(11):862-874. PubMed ID: 34481731
[TBL] [Abstract][Full Text] [Related]
15. PI3K inhibitors protect against glucocorticoid-induced skin atrophy.
Agarwal S; Mirzoeva S; Readhead B; Dudley JT; Budunova I
EBioMedicine; 2019 Mar; 41():526-537. PubMed ID: 30737086
[TBL] [Abstract][Full Text] [Related]
16. SUMO conjugation as regulator of the glucocorticoid receptor-FKBP51 cellular response to stress.
Liberman AC; Budziñski ML; Sokn C; Gobbini RP; Ugo MB; Arzt E
Steroids; 2020 Jan; 153():108520. PubMed ID: 31604074
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.
Leach DA; Trotta AP; Need EF; Risbridger GP; Taylor RA; Buchanan G
Prostate; 2017 Feb; 77(2):185-195. PubMed ID: 27718274
[TBL] [Abstract][Full Text] [Related]
18. Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52).
Sivils JC; Storer CL; Galigniana MD; Cox MB
Curr Opin Pharmacol; 2011 Aug; 11(4):314-9. PubMed ID: 21511531
[TBL] [Abstract][Full Text] [Related]
19. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding.
Denny WB; Valentine DL; Reynolds PD; Smith DF; Scammell JG
Endocrinology; 2000 Nov; 141(11):4107-13. PubMed ID: 11089542
[TBL] [Abstract][Full Text] [Related]
20. The stress regulator FKBP51: a novel and promising druggable target for the treatment of persistent pain states across sexes.
Maiarù M; Morgan OB; Mao T; Breitsamer M; Bamber H; Pöhlmann M; Schmidt MV; Winter G; Hausch F; Géranton SM
Pain; 2018 Jul; 159(7):1224-1234. PubMed ID: 29533388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
